Crossmark

Guar Gum Micro-particles for Targeted Co-delivery of Doxorubicin and Metformin HCL for Improved Specificity and Efficacy Against Colon Cancer: In Vitro and In Vivo Studies

Crossref DOI link: https://doi.org/10.1208/s12249-019-1589-3

Published Online: 2020-01-03

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kang, Rajveer Kaur

Mishr, Neeraj

Rai, Vineet Kumar
License Information

Text and Data Mining valid from 2020-01-03

Version of Record valid from 2020-01-03
More Information

Article History

Received: 30 August 2019

Accepted: 20 November 2019

First Online: 3 January 2020

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below